Table 5 Particle penetration (50% cut-point) through respiratory tract regions relative to particles entering the respiratory tract
From: Thoracic and respirable particle definitions for human health risk assessment
V daily(%-tile) | Normal | Gradual | ||||||
|---|---|---|---|---|---|---|---|---|
Augmenter | Mouth-breather | Augmenter | Oral only | |||||
P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | P(ET) avg | P(TB) avg | |
Male | ||||||||
5% | 2.94 a | 2.74 | 5.15 | 4.32 | 3.60 | 3.25 | 9.00 | 6.67 |
95% CI | (1.72–5.03) | (1.65–4.34) | (3.12–8.48) | (2.84–6.10) | (2.11–6.11) | (2.00–4.98) | (5.86–13.8) | (5.00–8.14) |
50% | 2.46 | 2.30 | 5.09 | 4.30 | 3.37 | 3.05 | 8.09 | 6.11 |
95% CI | (1.44–4.20) | (1.38–3.71) | (3.14–8.26) | (2.86–5.88) | (1.99–5.67) | (1.88–4.65) | (5.26–12.4) | (4.58–7.34) |
95% | 2.14 | 2.03 | 5.08 | 4.31 | 3.19 | 2.90 | 7.61 | 5.89 |
95% CI | (1.25–3.66) | (1.20–3.32) | (3.16–8.16) | (2.89–5.83) | (1.90–5.33) | (1.79–4.44) | (4.95–11.7) | (4.38–7.07) |
Female | ||||||||
5% | 2.92 | 2.71 | 4.32 | 3.78 | 3.10 | 2.86 | 8.78 | 6.50 |
95% CI | (1.71–5.01) | (1.63–4.28) | (2.57–7.22) | (2.40–5.52) | (1.81–5.30) | (1.73–4.48) | (5.71–13.5) | (4.88–7.91) |
50% | 2.42 | 2.27 | 4.46 | 3.87 | 2.91 | 2.68 | 7.88 | 5.96 |
95% CI | (1.41–4.13) | (1.36–3.64) | (2.72–7.32) | (2.51–5.45) | (1.71–4.94) | (1.63–4.19) | (5.13–12.1) | (4.47–7.17) |
95% | 2.10 | 1.99 | 4.58 | 3.96 | 2.74 | 2.54 | 7.44 | 5.77 |
95% CI | (1.23–3.60) | (1.18–3.26) | (2.82–7.42) | (2.60–5.49) | (1.61–4.64) | (1.53–4.00) | (4.84–11.4) | (4.29–6.94) |
Child-B b | ||||||||
5% | 2.77 | 2.61 | 4.31 | 3.78 | 4.30 | 3.78 | 8.34 | 6.46 |
95% CI | (1.62–4.75) | (1.56–4.18) | (2.58–7.19) | (2.40–5.57) | (2.57–7.17) | (2.40–5.56) | (5.42–12.8) | (4.74–8.04) |
50% | 2.25 | 2.13 | 4.37 | 3.81 | 4.07 | 3.59 | 7.50 | 5.81 |
95% CI | (1.31–3.85) | (1.27–3.48) | (2.67–7.15) | (2.47–5.35) | (2.46–6.71) | (2.29–5.15) | (4.88–11.5) | (4.32–7.08) |
95% | 1.89 | 1.81 | 4.34 | 3.76 | 3.98 | 3.49 | 6.91 | 5.33 |
95% CI | (1.11–3.24) | (1.07–2.98) | (2.69–7.03) | (2.48–5.11) | (2.45–6.47) | (2.27–4.88) | (4.49–10.6) | (4.01–6.36) |
Child-A c | ||||||||
5% | 3.92 | 3.56 | 5.60 | 4.72 | 5.59 | 4.72 | 8.34 | 6.46 |
95% CI | (2.29–6.72) | (2.18–5.44) | (3.38–9.28) | (3.09–6.63) | (3.37–9.27) | (3.09–6.62) | (5.42–12.8) | (4.74–8.04) |
50% | 3.18 | 2.94 | 5.37 | 4.53 | 5.12 | 4.36 | 7.50 | 5.81 |
95% CI | (1.86–5.45) | (1.77–4.58) | (3.29–8.77) | (3.03–6.10) | (3.11–8.40) | (2.88–5.95) | (4.88–11.5) | (4.32–7.08) |
95% | 2.68 | 2.50 | 5.16 | 4.34 | 4.85 | 4.14 | 6.91 | 5.33 |
95% CI | (1.56–4.58) | (1.50–3.97) | (3.19–8.34) | (2.94–5.66) | (2.98–7.90) | (2.76–5.51) | (4.49–10.6) | (4.01–6.36) |